Kantor K, Prasko J, Ociskova M, Holubova M, Nesnidal V, Vanek J, Minarikova K, Hodny F, Slepecky M, Zatkova M. Unmet emotional, interpersonal, and treatment needs in patients with borderline personality disorder.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 180-197

Di Bella G, Di Bella L, Borghetto V, Moscato I, Costanzo E. A retrospective observational study on cases of osteosarcomas treated with a multitherapy: The rationale and effectiveness.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 173-179

Xing C, Chen W, Li D, Li Y, Zhu X. Association of thyroid hormones and white matter hyperintensity in patients without intracranial arterial stenosis.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 167-172

Yamaguchi N, Yamada E, Matsumoto S, Nakajima Y, Nobusawa S, Yokoo H, Sekiguchi S, Yoshino S, Horiguchi K, Ishida E, Okada S, Yamada M. A case of insulinoma-induced hypoglycemia managed by Dexcom G4 Platinum.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 161-166

Piskinpasa H, Turgut S. The factors associated with the persistence of hypogonadism in male patients with prolactinoma.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 154-160

Tsuboi H, Matsunaga M, Tsujiguchi H, Kannon T, Hosomichi K, Sato T, Tajima A, Yoshida N, Hara A, Nakamura H. Elevated ratio of serum anandamide to arachidonic acid intake in community-dwelling women with high depressive symptoms.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 145-153

Lee H, Kim Y, Jin H, Lee K. Primary aldosteronism presenting as embolic myocardial infarction.  Neuro Endocrinol Lett. 2022 Sep;  43(3): 140-144